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Abstract Adhesive capsulitis is a musculoskeletal con-
dition that has a disabling capability. This review discusses
the diagnosis and both operative and nonoperative man-
agement of this shoulder condition that causes signiﬁcant
morbidity. Issues related to medications, rehabilitation, and
post surgical considerations are discussed.
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Introduction
The shoulder is a unique anatomical structure with an
extraordinary range of motion (ROM) that allows us to
interact with our environment. A loss of mobility of this
joint will cause signiﬁcant morbidity. Adhesive capsulitis
is a poorly understood musculoskeletal condition that can
be disabling. Adhesive capsulitis is diagnosed by numerous
physical characteristics including a thickening of the
synovial capsule, adhesions within the subacromial or
subdeltoid bursa, adhesions to the biceps tendon, and/or
obliteration of the axillary fold secondary to adhesions
[1–9]. Since Duplay initially described a case report of
adhesive capsulitis almost 130 years ago, this condition
remains an enigmatic shoulder disorder that causes pain
and restricted ROM at the glenohumeral joint [10].
Incidence
Adhesive capsulitis has an incidence of 3–5% in the gen-
eral population and up to 20% in those with diabetes. This
disorder is one of the most common musculoskeletal
problems seen in orthopedics [11–15]. Although some have
described adhesive capsulitis as a self-limiting disorder that
resolves in 1–3 years [13, 16–20], other studies report
ranges of between 20 and 50% of patients with adhesive
caspulitis which suffer long-term ROM deﬁcits that may
last up to 10 years [21–25].
The typical patient that develops adhesive capsulitis is a
female in her 5th to 7th decade of life [17, 23]. There is
generally no preference for handedness and adhesive cap-
sulitis rarely occurs simultaneously bilaterally [17, 23].
However, others have reported that it can occur sequen-
tially bilaterally in up to 40–50% of patients [26]. Adhesive
capsulitis is commonly associated with other systemic and
nonsystemic conditions. By far the most common is the
co-morbid condition of diabetes mellitus, with an incidence
of 10–36% [14, 27, 28].
Other co-morbid conditions include hyperthyroidism,
hypothyroidism, hypoadrenalism, Parkinson’s disease,
cardiac disease, pulmonary disease, stroke, and even sur-
gical procedures that do not affect the shoulder such as
cardiac surgery, cardiac catheterization, neurosurgery, and
radical neck dissection [29–39].
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DOI 10.1007/s12178-008-9031-6Wolf and Green [40] prospectively evaluated 100 con-
secutive patients with adhesive capsulitis with use of
several forms of questionnaires. Patients with more com-
orbidities had signiﬁcantly lower and poorer scores on
shoulder assessment forms, social function, and emotional
and mental health.
Adhesive capsulitis classiﬁcation
Adhesive capsulitis is classiﬁed into two categories: (1)
primary, which is insidious and idiopathic, or (2) second-
ary, which is generally due to trauma or subsequent
immobilization [41]. Those with primary adhesive capsu-
litis generally have a very gradual onset and progression of
symptoms, with no known precipitating event that can be
identiﬁed [42]. These symptoms may progress so slowly
that the patient does not even seek medical attention until
ROM and pain severely limit their daily activities. It is not
uncommon for a patient to present with shoulder pain as
their only complaint and not realize there is a loss of
motion. This is unlike the person afﬂicted with a secondary
adhesive capsulitis who usually notices their symptoms
soon after a fall or inciting trauma as their ROM does not
appear to improve as expected after the pain from the
inciting event should no longer limit ROM.
Clinical phases
Adhesive capsulitis presentation is generally broken into
three distinct stages [43]. The ﬁrst stage that is described is
called the freezing or painful stage. Patients may not
present during this stage because they think that eventually
the pain will resolve if self-treated. As the symptoms
progress, pain worsens and both active and passive ROM
becomes more restricted, eventually resulting in the patient
seeking medical consultation. This phase typically lasts
between 3 and 9 months and is characterized by an acute
synovitis of the glenohumeral joint [44].
Most patients will progress to the second stage, the
frozen or transitional stage. During this stage shoulder pain
does not necessarily worsen. Because of pain at end ROM,
use of the arm may be limited causing muscular disuse.
The frozen stage lasts anywhere 4 to 12 months [44]. The
common capsular pattern of limitation has historically been
described as diminishing motions with external shoulder
rotation being the most limited, followed closely by
shoulder ﬂexion, and internal rotation. There eventually
becomes a point in the frozen stage that pain does not occur
at the end of ROM.
The third stage begins when ROM begins to improve.
This 3rd stage is termed the thawing stage. This stage lasts
anywhere from 12 to 42 months and is deﬁned by a gradual
return of shoulder mobility.
Pathology
Pain associated with adhesive capsulitis can cause a limi-
tation or selective immobilization of the painful shoulder.
Prolonged immobilization of a joint has been shown to
cause several detrimental pathophysiologic ﬁndings
including: decreased collagen length, ﬁbrofatty inﬁltration
into the capsular recess, ligament atrophy resulting in
decreased stress absorption, collagen band bridging across
recesses, random collagen production, and altered sarco-
mere number in muscle tissue [45].
Evaluation
The evaluation of adhesive capsulitis starts with a thorough
shoulder history. Inciting events such as mild trauma are
often given in relation to the shoulder pain. This may be
something very trivial, and in fact may not be related to the
process, but the patient may recall something that is attrib-
uted to starting the process. Adhesive capsulitis often
involves the non-dominant extremity. This is because it is
easier to protect and not use the extremity because it is
painful and the dominant extremity can do the work. When
the extremity is held close to the body, often to ‘‘protect it’’,
the process can then proceed unchecked. Thisbecomes even
more apparent when passive ROM is accompanied by an
unusual amount of pain and guarding. Codman [18] dis-
cussedthisentitydescribingaslowonsetofpain,feltnearthe
insertionofthedeltoid,inabilitytosleepontheaffectedside,
andrestrictioninbothactiveandpassiveelevationaswellas
external rotation, yet with normal radiologic appearance.
Without degenerative joint disease on radiographs, this
clinicalpicturesuggeststhediagnosisofadhesivecapsulitis.
The physical examination is marked by the loss of both
passive and active range of motion. This motion may also
be painful as the capsule reaches its stretching point.
Examination tests for other shoulder abnormalities can also
be positive. Testing for impingement may be positive with
a Hawkin’s or Neer sign; however, the pain is likely from
the intrinsic process of impingement or capsular stretch
rather than from adhesive capsulitis.
The diagnosis of adhesive capsulitis is often one of
exclusion. Early in the disease process adhesive capsulitis
may clinically appear similar to other shoulder conditions
such as major trauma, rotator cuff tear, rotator cuff con-
tusion, labral tear, bone contusion, subacromial bursitis,
cervical or peripheral neuropathy. Additionally, a history
of a previous surgical procedure can lead to shoulder
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and if radiographs do not demonstrate osteoarthritis, then
the diagnosis can be given.
A screening radiograph of the shoulder is imperative to
diagnose adhesive capsulitis. This rules out other possible
diagnosis of loss of ROM that include osteoarthritis, or
chronic anterior or posterior dislocation.
Non-operative treatment
Anti-inﬂammatories
Treatment of adhesive capsulitis often involves the use of
anti-inﬂammatories, or corticosteroids. NSAIDs may be
used during any phase as an attempt to relieve symptoms.
There are no well done studies to indicate that NSAIDs
change the natural history of adhesive capsulitis. There is a
paucity of literature that even would support the use of
NSAIDS for this diagnosis. However, NSAIDS are not
only anti-inﬂammatories, they are analgesics and are a
reasonable ﬁrst choice for treatment.
A summary of studies related to oral corticosteroids can
be seen in Table 1. There are no randomized studies
comparing oral corticosteroids with placebo or natural
history of the condition. Most studies seem to show that
corticosteroids may reduce pain early on better than reha-
bilitation or placebo but their beneﬁts are not maintained
long term. Their risks and beneﬁts therefore must be
strongly considered before using them since long-term
beneﬁt is not supported. They may be considered when
short-term gain is necessary for a particular event.
Intra-articular corticosteroid injections
Although high-quality randomized studies of corticosteroid
injection for treatment of adhesive capsulitis have not been
done, there is some evidence to indicate there is a short-term
beneﬁt with their use. Given the low likelihood of compli-
cations with this approach, the use of either a subacromial
injection or glenohumeral injection should be considered.
One limitation to using this form of treatment comes upon
recent evidence that injections performed blindly may be
inaccurate in approximately 60% of cases. Better clinical
outcome is found with greater accuracy [46, 47]. This
problem may be overcome with the use of ultrasound gui-
ded joint injection. Please see Table 2 for studies related to
intra-articular cortisone injections for adhesive capsulitis.
Capsular distension injections
This method of treatment has been described for patients
under local anesthesia. The joint is injected to its limits
with local anesthetic to attempt to stretch the capsule. This
technique is often poorly tolerated because of pain that is
experienced during the process as the entire shoulder is not
anesthetized from the intra-articular injection [48].
Surgical treatment
The treatment of adhesive capsulitis should lead to the
operating room only after a concerted effort at conservative
management has failed. There is not a discrete timeline to
head to surgery. As a general rule patients should have
participated in some form of therapy for at least 2 months,
and shown no progress. Patients should feel they are not
making progress and have signiﬁcant pain and limitations
of occupation, recreation, or sleep to proceed with surgical
intervention.
Manipulation under anesthesia
Manipulation under anesthesia as a means of treatment has
been advocated. This method allows return of ROM in the
operating room. Immediate postoperative physical therapy
can be initiated with this form of treatment [49]. Manipu-
lation under anesthesia has the disadvantage in that tissues
that are stretched while the patient is under anesthesia may
cause pain when awake. This can potentially slow recov-
ery. When surgical release is added to this procedure it
induces further surgical trauma to the shoulder and may
slow rehabilitation.
Arthroscopic release and repair
Arthroscopy is an excellent additional tool for addressing
the shoulder with adhesive capsulitis, and has become well
accepted in treating this process. The essential lesion is the
tightened coracohumeral ligament and rotator interval with
the contracted capsule including the axillary pouch. These
structures can be treated by release with arthroscopic
instruments. The contracted structures are released to allow
ROM to return with manipulation if necessary. The release
can be performed either before, during, or after the
manipulation with favorable results (Fig. 1)[ 50–60]. The
manipulation may need to precede the procedure to gain
access to the joint. Arthroscopy allows a full evaluation of
the shoulder anatomy as well. Any abnormalities that may
not have been diagnosed and that may have contributed to
the development of the condition can be addressed. This
may make postoperative ROM less painful and recovery
time decreased.
Operative treatment of adhesive capsulitis has been
shown to decrease the duration of the disease and to return
ROM with good success. Total recovery of pain-free ROM
averages 2.8 months (1–6), and time for formal physical
182 Curr Rev Musculoskelet Med (2008) 1:180–189Table 1 Description of published randomized controlled trials of oral corticosteroids for adhesive capsulitis
Study and date
published
Number of
shoulders
Active intervention Control
intervention
Results
Blockey and Wright
[62], 1954
32 Cortisone acetate (200 mg daily for
3 days, then 100 mg daily for
11 days, then dose tapered off in
decrements of 12.5 mg every
2 days, total dose = 2.5 g over
4 weeks. If unsatisfactory progress
after 4 weeks, manipulation under
general anaesthesia; followed by a
second 4 week course of cortisone
acetate
Placebo No statistical analysis of between-group
differences reported, although an
earlier clinically important
improvement in both pain and range of
motion was noted in the oral steroid
group: mean pain scores (measured on
a 4-point categorical scale converted
into an interval scale, where none = 0,
slight = 1, moderated = 2,
severe = 3) at baseline, 1, 4, and
18 weeks were 1.4, 0.9, 0.5, 0.6 in the
steroid group, and 1.4, 1.3, 0.8, 0.5 in
the control group; total shoulder
abduction was 82, 103, 125, 153 in the
steroid groups and 75, 89, 106, 154 in
the control group. The number of
participants requiring manipulation
after 4 weeks was 6/15 (40%) and 11/
16(68.8%) in the steroid and placebo
groups, respectively (RR = 0.58
(0.29–1.17))
Kessel et al. [63], 1981 32 Prednisolone (15 mg daily for 4
weeks) and manipulation (after
2 weeks of oral steroids)
Manipulation No statistical analysis was done but
‘‘dramatic response’’ to manipulation in
7/12 (58.3%) participants taking oral
steroids compared with 5/16 (31.25%)
taking placebo. Effect of manipulation
on ﬁnal range of motion at 6, 12, and
18 weeks following the procedure also
favored the steroid group but again the
differences between groups were
normally not formally analyzed
Binder et al. [23], 1986 40 Prednisolone (10 mg daily for 4
weeks, then 5 mg daily for 2 weeks
No treatment The pattern of improvement in pain at
night over 8 weeks showed a
signiﬁcant difference in favor of oral
prednisolone with a more rapid initial
recovery, although by 5 months the
difference between the groups was
negligible. Improvement in pain at rest
and with movement, range of motion,
and a cumulative recovery curve were
not signiﬁcantly different between
groups over 8 months
Buchbinder et al. [64],
2004
50 Prednisolone (30 mg daily for
3 weeks)
Placebo Greater improvement in overall pain in
oral steroid group than in placebo
group at 3 weeks. There was also
greater improvement in disability,
range of motion and participant rated
improvement in 22/23 (96%) oral
steroid, vs. 11/23 (48%) in placebo
group. At 6 weeks, analysis favored the
oral steroid group for most outcomes
but none of the differences was
signiﬁcant. At 12 weeks, the analysis
tended to favor the placebo group. A 3
week course of 30 mg prednisolone
daily is of signiﬁcant short-term beneﬁt
in adhesive capsulitis but beneﬁts are
not maintained beyond 6 weeks
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vation improved from the average of 92–165 and external
rotation with the elbow at the side improved from 12 to 56
in a series of 68 shoulders treated with arthroscopic cap-
sular release [61]. With the added diagnostic abilities of
arthroscopy and the favorable return of ROM that is
improved over manipulation alone, arthroscopy should be
considered if conservative treatment fails.
Rehabilitation
Multiple studies have looked at the efﬁcacy of rehabilita-
tion following adhesive capsulitis. A list of randomized
controlled, prospective and retrospective clinical trials can
be seen in Table 3. In general, most of these studies
demonstrate various degrees of improvement in pain
scores, ROM, and function following various treatment
modes.
Patient education
Because adhesive capsulitis is so painful and has a very
slow progression of resolution, patient education is critical
for success. Patients should be educated in the chronicity of
this condition. If they know and understand ahead of time
that it can be several years before symptoms are completely
resolved, apprehension and a feeling of urgency for func-
tional return may be decreased.
Fig. 1 Arthroscopic photo of axillary pouch after manipulation
showing thickness of capsule and axillary nerve in a left shoulder
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Adhesive capsulitis is a common shoulder condition. There
is often a delay of patient presentation, and sometimes delay
in diagnosis as it can share symptoms with many other
shoulder conditions. Typical history is that of minor or no
trauma with the gradual progression of pain and loss of
ROM. The hallmark of physical examination is loss of both
passive and active ROM without degenerative changes on
X-ray. A combination of pharmacological, rehabilitative,
and/or surgical treatment is commonly helpful for the
patient afﬂicted with adhesive capsulitis. Comorbid factors
may play a key role in length and amount of recovery.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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